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Abstract
The mechanisms that regulate the host immune response induced by human metapneumovirus (hMPV), a newly-
recognized member of the Paramyxoviridae family, are largely unknown. Cytokines play an important role in modulating
inflammatory responses during viral infections. IL-12p40, a known important mediator in limiting lung inflammation, is
induced by hMPV and its production is sustained after the resolution phase of infection suggesting that this cytokine plays
a role in the immune response against hMPV. In this work, we demonstrated that in mice deficient in IL-12p40, hMPV
infection induced an exacerbated pulmonary inflammatory response and mucus production, altered cytokine response, and
decreased lung function. However, hMPV infection in these mice does not have an effect on viral replication. These results
identify an important regulatory role of IL-12p40 in hMPV infection.
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Introduction
Human metapneumovirus (hMPV) is an emerging RNA virus of
the Paramyxoviridae family that causes clinical syndromes ranging
from mild illnesses, such as common cold, to more devastating
conditions, such as bronchiolitis and pneumonia, [1], [2] similar to
that seen in respiratory syncytial virus (RSV) infection. Identifi-
cation and isolation of the virus was achieved in 2001 from
nasopharyngeal aspirates of young children with respiratory
disease [3] and it is currently recognized as a global and significant
respiratory pathogen. Serological evidence indicate that hMPV
seropositivity is almost universal by 5 years of age [3], [4] and by
the age of 25, all adults have been infected with this virus [5]. The
nosocomial impact of hMPV is estimated to be as high as that for
RSV. hMPV is responsible for 5 to 15% of hospitalizations of
children suffering from acute respiratory tract infections [6], [7],
[8]. Elderly patients are also a target population for hMPV
infection since outbreaks of hMPV have been reported in long
term care facilities with high mortality rate in frail elderly residents
[9], [10], [11], [12].
The immune response triggered by respiratory viruses plays
a major role in the resolution of the virus-induced disease and host
protection. Despite the significant progress made in the last ten
years toward understanding the nature of hMPV infection [13],
there remain significant questions regarding the immune response
induced by this virus. hMPV is able to induce the production of
several cytokines and chemokines in the human [14] and mouse
[15] respiratory tract. Likely such mediators play crucial roles in
mediating recovery from the viral infection. Therefore, the
regulation of the immune response by specific cytokines in hMPV
infection warrants further investigation. IL-12p40 is a regulatory
cytokine that is induced and distinctly sustained during the course
of hMPV infection [15], but the role of this cytokine in the context
of the pathogenesis induced by hMPV, is currently unclear. IL-
12p40 is a component of IL-12p70 and was shown to associate not
only with the IL-12 p35 chain, but also with a p19 chain to form
a covalently linked heterodimeric cytokine, IL-23 [16]. IL-12p40
can also be secreted as a monomer (IL-12p40) and as a homodimer
(IL-12p80) [17]. IL-12p40 is often secreted in large excess over
p70 heterodimer, p35 is only secreted as a part of the heterodimer
when p40 is also produced by the same cells [16]. IL-12p40 is
produced primarily by activated macrophages, dendritic cells
(DC), neutrophils and microglia [16], [18], but it also produced by
keratinocytes [19] and airway epithelial cells [20], [21]. Different
functions have been attributed to IL-12p40, initially as an
antagonist of IL-12p70 activity [17], [22], [23]. However, in
contrast to this negative regulatory role, it has been reported that
this cytokine plays a pivotal agonistic role in initiating the immune
response [24] and performs several immunostimulatory functions
like DC migration [25], macrophage inflammation [26], [27], and
to trigger IFN-c production by NK [28] and T cells [16].
Furthermore, several reports have provided convincing evidence
indicating a regulatory role of IL-12p40 in pulmonary inflamma-
tion and host immune responses in experimental models of asthma
[29] and infectious diseases [30], [31], [32]. However, the role that
IL-12p40 plays in hMPV infection, has not yet been elucidated.
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inflammatory and immune responses in an experimentally in-
duced hMPV infection by using IL-12p40-deficient mice. Our
results indicate that IL-12p40 plays a major role in limiting hMPV
disease by controlling body weight loss, reducing lung inflamma-
tion and airway mucus production and regulating pulmonary cell
infiltration and cytokine release. However, the absence of IL-
12p40 did not have a major impact in lung viral replication. These
studies indicate a significant contribution of IL-12p40 to the
protective host response to hMPV.
Results
IL-12p40 production in hMPV infection is sustained and
its absence exacerbates disease severity
In order to determine the role of IL-12p40 in the regulation of
disease severity during hMPV infection, the production of IL-
12p40, body weight loss, and lung viral replication were assessed.
WT C57BL/6 and IL-12p40-KO mice were infected intranasally (
i.n.) with hMPV (5610
6 PFU/mouse), monitored daily and
bronchoalveolar lavage (BAL) fluid was analyzed at different time
points after infection. As shown in Fig. 1A, hMPV induced the
release of IL-12p40 in BAL samples of C57BL/6 mice as early as
day 1 after infection and the production of this cytokine remained
sustained beyond the resolution of the infection (day 11, latest time
point tested). Moreover, the induction of IL-12p40 was dependent
of viral replication since UV inactivation of the virus resulted in
a significant reduction of the production of the cytokine (Fig. 1A).
In addition, the absence of IL-12p40 exacerbated the disease
severity of hMPV-infected mice. As shown in Fig. 1B, IL-12p40-
KO mice exhibited more body weight loss (26%) than WT mice
(8%) at the peak of the clinical disease at day 6. Furthermore,
a delayed recovery to baseline weight in IL-12p40-KO mice was
also observed since those mice reached similar values to mock-
infected mice at day 15 after infection versus at day 10 in the WT
group (Fig. 1B). To determine whether the exacerbation of body
weight loss was related to an altered viral replication in the
deficient mice, hMPV-infected IL-12p40-KO and WT mice were
sacrificed at day 1, 3, 5, and 7 after infection and total lung tissue
was collected to determine virus replication by plaque assay.
Resulting viral titers showed that hMPV replicates in the lungs of
WT and IL-12p40-KO mice with a peak of viral titer at day 5 after
infection. However, no difference between both groups of animals
was observed in any time point tested (Fig. 1C). Differences in viral
replication were confirmed by the analysis of viral gene expression
in the lungs at day 5 after infection (peak of viral replication),
where the virus was detected in the infected animals, but in similar
amounts when compared WT and IL-2p40-KO mice (Fig. 1D).
Lack of IL-12p40 exacerbates pulmonary inflammation in
hMPV-infected mice
Next, we determined the role of IL-12p40 in the regulation of
lung inflammation in response to hMPV infection. Pathology score
and differential cell count in BAL fluid were assessed in WT and
IL-12p40-KO mice. Groups of animals were infected i.n. with
5610
6 PFU of hMPV and lung tissue and BAL fluid were
harvested at day 7 after infection (when pulmonary inflammation
peaks [33]). Lung sections were processed and stained by
Hematoxylin and eosin (H&E) and cells from BAL samples were
counted, cytospun and analyzed for differential cell analysis. Lung
histopathology analysis demonstrated that no airway inflammation
was observed in mock-infected WT or KO mice (Fig. 2A, upper
panels). However, hMPV infection induced a cellular infiltration
in the perivascular and peribronchial spaces of WT mice (Fig. 2A,
lower left panel) which was exacerbated in the absence of IL-
12p40 (Fig. 2A, lower right panel). Quantification of the
pulmonary inflammation, represented as pathology score, in-
dicated that the inflammation in the respiratory tract of IL-12p40-
KO mice was increased over two-fold when compared to WT
animals (Fig. 2B).
The effect of IL-12p40 on pulmonary inflammation was
confirmed by the analysis of the cell populations in BAL samples.
As shown in Fig. 3A, the total number of macrophages,
neutrophils, and lymphocytes was increased after hMPV infection.
Moreover, in the absence of IL-12p40, the number of macro-
phages and neutrophils was significantly increased in the BAL
samples from IL-12p40-KO mice infected with hMPV as
compared with that of WT hMPV-infected. In particular, an
exacerbated increase in BAL neutrophils was noted in IL-12p40-
KO (2.3610
560.2) vs WT (0.7610
560.05) hMPV-infected mice.
Numbers of lymphocytes were increased after hMPV infection,
but no significant difference was observed when WT and KO
groups of mice were compared. No eosinophils were observed in
the BAL samples of any of the groups of mice analyzed. Alveolar
macrophages were mostly recovered from samples of mock-
infected mice in both groups of animals (Fig. 3B, upper panels).
After hMPV infection, an increased frequency of lymphocytes and
neutrophils was observed. As shown in Fig. 3B (lower panels), the
frequency of neutrophils in the alveolar spaces was further
exacerbated in the absence of IL-12p40.
Increased goblet cell formation and mucin gene
expression in the airways of IL-12p40-KO mice following
hMPV infection
Increased production of mucus in the airways is usually
correlated with exacerbated lung inflammation. In order to
determine whether the absence of IL-12p40 would also alter the
mucus production, the presence of mucin-expressing goblet cells in
the airways as well as the expression of mucins in lung, were
investigated. Lung sections from mice infected i.n. with
5610
6 PFU of hMPV, were collected at day 7 after infection
[same time point as in the determination of pulmonary in-
flammation, (Fig. 2)]. Periodic acid-Schiff (PAS) staining was used
to detect mucin-expressing cells in the airway epithelium. In mock-
infected WT and IL-12p40-KO mice, the presence of goblet cells
was almost absent (Fig. 4A, upper panels). However, after hMPV
infection, the number of goblet cells was increased in the airways
of WT mice (Fig. 4A, left lower panel) and further exacerbated in
those mice lacking the expression of IL-12p40 (Fig. 4A, right lower
panel). Quantification of mucus producing cells in the airways was
determined by assessing the mucus index (as described in
Methods). As shown in Fig. 4B, the mucus index was increased
after hMPV infection in WT mice. Furthermore, we observed an
increased mucus index in the absence of IL-12p40 by more than
two times when compared to WT mice infected with hMPV. In
order to confirm the exacerbated mucus production as indicated
by the mucus index, in a separate set of experiments, the
expression of mucin 5 subtype AC (Muc5ac) and Muc5b was
investigated. Muc5ac and Muc5b have been implicated as markers
of goblet cell metaplasia in lung pathologies based upon expression
studies in humans, in animal models, and in cell cultures [34],
[35], [36]. Therefore, lung tissue was collected at day 7 after
hMPV infection to quantify the expression of the mucins by
quantitative RT-PCR. As shown in Fig. 4C, the expression of
Muc5ac was modestly induced after hMPV infection in WT mice
when compared to WT mock- infected mice. However, following
hMPV infection, the absence of IL-12p40 exacerbated Muc5ac
expression over 8 times when compared to WT mice. On the
IL-12p40 in Human Metapneumovirus Infection
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mice, as similar expression was observed in mock-infected mice.
However, it was increased in IL-12p40-KO mice after hMPV
infection, although in less magnitude than Muc5ac. Thus, the
absence of IL-12p40 resulted in significantly increased mucin
expression in the airways of hMPV-infected mice.
IL-12p40 expression regulates the production of IFN-c, IL-
6, CXCL10, CCL11, CXCL1 and CCL2 in mice infected with
hMPV
To define the role of IL-12p40 in the regulation of hMPV-
induced cytokine response, the level of cytokines and chemokines
was assessed in IL-12p40-KO mice and compared to WT ones.
Mice were infected i.n. with hMPV, and at day 7 after infection,
BAL samples were collected from each group of mice and assessed
for the presence of cytokines by using a multi-plex cytokine
detection system. Our data indicate that, compared to immuno-
competent mice, the lack of IL-12p40 significantly decreased the
production of the Th1 regulatory cytokine IFN-c and the
proinflammatory cytokine IL-6 by 65% and 82%, respectively
(Fig. 5). A similar effect was observed with the release of the
chemokines CXCL10 (IP-10) and CCL2 (MCP-1), where their
production was decreased by over 60% in both cases. On the other
hand, the production of CCL11 (Eotaxin) and CXCL1 (KC, IL-8
homologue), cytokines that regulates the chemotaxis and function
of neutrophils and eosinophils, was upregulated in the absence of
IL-12p40. Expression of CCL11 and CXCL1 was increased over
two times in the deficient mice in response to hMPV infection
when compared to WT mice. Finally, production of CXCL2
(MIP-2), CCL4 (MIP-1b), CCL3 (MIP-1a), and CXCL9 (MIG)
was induced after hMPV infection but no changes were observed
in IL-12p40-KO vs WT mice (not shown). Overall, these data
indicate that IL-12p40 regulates the cytokine response in hMPV
infected mice.
Increased decline in lung function in IL-12p40-KO mice
infected with hMPV
To assess the role of IL-12p40 on pulmonary function after
hMPV infection, WT and IL-12p40-KO mice were infected with
Figure 1. Disease severity and lung viral replication in the absence of IL-12p40. Mice (7–10 week old) were inoculated with PBS (mock) or
infected i.n. with 5610
6 PFU of hMPV. (A) Bronchoalveolar lavage was collected at different time points from mock, hMPV-infected and UV-
inactivated hMPV-infected mice and IL-12p40 was determined by Bio-Plex Pro
TM assay. n=5 mice/group. (B) Mice were monitored daily and body
weight was calculated based on the original weight before the infection. n=3 mice/group. (C) Total lung tissue was harvested at different time points
and lung infectious viral particles were titrated on LLC-MK2 cell monolayers by methylcellulose plaque assay. n=4 mice/group. (D) hMPV N gene
expression in the lung of infected mice was determined by real-time RT-PCR. n=3 mice/group. *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0037173.g001
IL-12p40 in Human Metapneumovirus Infection
PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e37173hMPV (or mock infected as baseline control) and then invasive
assessment of lung function 15 days later was conducted. No
differences in lung resistance were observed between the WT and
IL-12p40-KO groups at concentrations of methacholine of 0.1
and 1.0. However, administration of higher concentrations of
methacholine revealed significant functional changes in IL-12p40-
KO mice. When compared to WT, deficient animals showed over
a two-fold increase of lung resistance at doses of 10, 25, and
50 mg/ml of methacholine. That difference was increased one
more fold when compared to mock-infected groups (Fig. 6).
Discussion
Human metapneumovirus induces a sustained production of IL-
12p40 in the lung of BALB/c [15] and C57BL/6 mice (Fig. 1A),
suggesting an important role in hMPV infection. In order to
determine the role of IL-12p40 in hMPV-induced pathogenesis,
we used an IL-12p40-KO mouse model of infection. A series of
parameters including body weight loss, pulmonary inflammation
and mucus production, viral replication, production of cytokines,
cellular infiltration in the lung, and lung function were determined
to assess hMPV pathogenesis. The present study shows that the
absence of IL-12p40 in hMPV-infected mice induced an
exacerbated inflammatory response as well as increased numbers
of goblet cells and body weight loss. Those findings go in line with
the reduced lung function observed in this model. Cytokine
secretion was also perturbed by the lack of IL-12p40, but not the
viral replication in the lung. These data indicate that IL-12p40
plays an important regulatory role in the pathogenesis induced by
hMPV infection.
The production of IL-12p40 was detected in BAL samples of
hMPV-infected C57BL/6 mice. Therefore, previous data report-
ing the production of IL-12p40 in BALB/c mice [15] were
reproduced in this work. We also observed that the induction of
the cytokine was dependent of viral replication as demonstrated by
the reduced amounts of IL-12p40 after the UV-inactivation of the
inoculum. Body weight loss is a parameter to monitor the severity
of the disease after hMPV infection [37]. In this study, the body
weight loss was increased in IL-12p40-KO mice, indicating that
IL-12p40 has a protective role against hMPV-induced illness.
Figure 2. Pulmonary inflammation in hMPV-infected IL-12p40-KO mice. C57BL/6 and IL-12p40-KO mice were infected i.n. with 5610
6 PFU
of hMPV or mock-treated and lungs were harvested at day 7 after hMPV infection, fixed for slide preparation and H&E stained. (A) Representative
stained lung tissue sections from the indicated treatment. Arrows indicate cells infiltrating the perivascular and peribronchial spaces, Scale
bar=200 mm. (B) Pathology score of prepared slides (scored as described in Materials and Methods). n=5 mice/group. **P,0.01.
doi:10.1371/journal.pone.0037173.g002
IL-12p40 in Human Metapneumovirus Infection
PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e37173Studies in BALB/c mice infected with RSV have shown, however,
that IL-12p40 does not influence weight loss in the infected mice,
suggesting that IL-12p40 distinctly regulates the host response
induced by these two paramyxovirus infections [38]. On the other
hand, the observed exacerbated disease in IL-12p40-KO mice
infected with hMPV does not seem to be dependent on viral
replication since no differences in lung viral titer or viral gene
expression were found in the absence or presence of IL-12p40.
This finding indicates that IL-12 is not essential to control lung
viral clearance. These data are consistent with studies reported in
RSV infection, where the lack of IL-12p40 did not alter the viral
replication in infected mice [31].
Pulmonary inflammation represents a critical host response to
control viral infections in the lung. However, an exacerbated
inflammatory response may result in a severe lung disease. In this
work, we showed that airway inflammation was increased in IL-
12p40-KO mice as compared with that of WT mice infected with
hMPV. Moreover, increased number of macrophages and
neutrophils was found in BAL samples of IL-12p40-KO mice,
consistent with the increased pathology score observed during
hMPV infection. Similar to the findings reported in the current
work, studies in an experimental model of RSV infection indicate
that the lack of IL-12p40 also exacerbated the recruitment of
inflammatory cells including macrophages and neutrophils at day
7 after infection [31], [38]. In addition, treatment of RSV-infected
mice with anti-IL-12 polyclonal antibodies also resulted in an
exacerbated lung inflammatory response at day 8 and 12 after
infection [39]. However, the data reported here is the first
evidence demonstrating that IL-12p40 plays a critical role in
controlling pulmonary inflammation during hMPV infection.
Furthermore, the observed exacerbated inflammatory response
was accompanied by a goblet cell hyperplasia and mucus
hypersecretion in IL-12p40-KO mice following hMPV infection.
Similar to our findings, the lack of IL-12p40 in a mouse model of
RSV infection increased the number of mucus-secreting cells [31].
Globlet cells are interspersed, and secrete mucins, which are high
molecular mass, highly glycosylated macromolecules that are the
major components of mucus secretions [40]. Mucus overproduc-
tion is common in pulmonary conditions such as bronchiolitis and
has been reported in mice infected with RSV and hMPV [31],
[41], [42]. The importance of mucins as defensive molecules in
adult airways is suggested by their abundance during homeostasis
and their up-regulation during inflammation. In this work, we
observed that only Muc5ac was induced after hMPV infection, but
not Muc5b. However, both mucins were upregulated in the
absence of IL-12p40, predominantly Muc5ac. Muc5b has been
identified as the predominant secreted gel-forming mucin
expressed in healthy adult murine lungs [43], [44], whereas
Muc5ac is the most predominantly induced gel-forming mucin in
antigen challenged murine lungs [43] and the one expressed by
human airway epithelial cells [45]. Overall, our data suggest that
Muc5ac is predominantly induced in the lungs of hMPV-infected
mice and its production is regulated by the expression of IL-12p40.
Production of several inflammatory mediators is induced after
hMPV infection [14], [15]. IL-12 has pleiotropic effects on NK
and T cells and induces CD4+ T cells to assume a Th1 phenotype
[16]. In the present study, the absence of IL-12p40 induced
a decreased production of the Th1-derived cytokine IFN-c, IL-6,
CCL2, and CXCL10 and exacerbated the expression of CCL11
and CXCL1. IFN-c is a critical cytokine for host defense against
viral infections, as it activates macrophages to kill intracellular
microbes [46]. In support of our observations, IFN-c production
has been reported to be downregulated in mice lacking IL-12p40
after infection with Mycobacterium tuberculosis [32]. However,
different to our work, in IL-12p40-KO mice infected with RSV,
the production of IFN-c remained unchanged [31]. This
discrepancy could be attributable to the different experimental
conditions. In particular, the different viral pathogens and the
distinct genetic background of the IL-12p40-KO mice used in
each experimental model. IFN-c can influence the production of
other cytokines including IL-6, CXCL10, CCL11, and CXCL1.
IL-6 is a multifunctional cytokine involved in the control of many
cell functions, including the activation of the immune system, stem
cell differentiation, the maintenance of bone homeostasis, and in
many neural functions [47]. Several reports indicate that IFN-c
enhances IL-6 gene expression and IL-6 production in monocytes
[48], [49]. It remains probable, therefore, that the reduced
production of IL-6 observed in IL-12p40-KO mice infected with
hMPV, might be a consequence of the observed decreased
production of IFN-c. The finding that IL-6 induces neutrophil
apoptosis [50] supports the notion that IL-6 substantially
contributes to the resolution of acute neutrophil infiltration.
However, whether the reduced production of IL-6 in IL-12p40-
KO mice was related to the increased numbers of neutrophils
found in the BAL samples, remains to be investigated. CXCL10
(IFN-c-inducible protein 10, IP-10) production is directly regulat-
Figure 3. Total differential cell counts in hMPV-infected IL-
12p40-KO mice. C57BL/6 and IL-12p40-KO mice were infected i.n.
with 5610
6 PFU of hMPV and BAL samples were harvested at day 7
after hMPV infection. Cell preparations were stained (Wright-Giemsa)
and counted under the microscope (200 cells/slide). Bar graph
represents mean 6 SEM. n=9 mice/group. *P,0.05, **P,0.01. (B)
Representative stained cytospin preparations from the indicated
treatment. Arrows indicate neutrophils infiltrating the alveolar spaces.
doi:10.1371/journal.pone.0037173.g003
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KO mice may be directly related to the lower production of IFN-
c.
On the other hand, IFN-c has an inhibitory activity on the
expression and secretion of IL-8 (CXCL1) [52], [53], [54],
suggesting that the downregulation of IFN-c production in mice
lacking IL-12p40 may have an impact on the production of
CXCL1 in hMPV-infected mice. IL-8 is a potent neutrophil
chemotactic and activating cytokine. Moreover, regulated re-
cruitment and clearance of neutrophils is the hallmark of
competent host defense and resolution of inflammation. Neutro-
phil recruitment after hMPV infection has been observed up to
day 7 (Fig. 3A) or up to day 14 [55]. In this work, the recruitment
of neutrophils was increased by the lack of IL-12p40. Therefore,
although not addressed in this work, there is the possibility that the
observed increased production of CXCL1 in hMPV-infected mice
in the absence of IL-12p40, can be correlated with the increased
recruitment of neutrophils in the same animals. IFN-c can also
regulate the production of CCL11. Studies in vitro indicate that
IFN-c is able to inhibit the production of CCL11 in fibroblasts
[56]. However, despite the increased amount of CCL11 in the
absence of IL-12p40, no eosinophils were found in hMPV-infected
IL-12p40-KO mice.
Previous studies have shown that lung function is decreased
after hMPV infection [55]. Based on the present observations, we
demonstrate that lung function in infected mice is regulated by IL-
12p40 as lung resistance was exacerbated in infected mice in the
absence of IL-12p40 (Fig. 6). This finding is in line with those from
Figure 4. Mucus production after hMPV infection in IL-12p40 deficient mice. C57BL/6 and IL-12p40-KO mice were infected i.n. with
5610
6 PFU of hMPV or mock-infected and lungs were harvested at day 7 after hMPV infection. (A) Lung tissue was fixed for slide preparation, PAS
stained and tissue sections were digitalized. Representative stained lung tissue sections from the indicated treatment. Mucus-producing cells in the
airways were identified by positive PAS staining. Scale bar=100 mm. (B) Each area of airway epithelium was measured to calculate the Mucus index
(as described in Materials and Methods). An average of 52 individual airways were measured per mouse. n=3 mice/group. (C) RNA was isolated from
the lungs of mock- and hMPV-infected mice (WT and KO) and transcribed into cDNA. Samples were assessed for expression of MUC5ac and MUC5b
using quantitative RT-PCR by SYBR green. Each sample was normalized using GAPDH control and the bar graphs represent average fold increase to
RNA obtained before infection. n=3 mice/group. *P,0.05.
doi:10.1371/journal.pone.0037173.g004
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and with the increased lung resistance of IL-12p40-KO mice after
acute or prolonged exposure to allergen [29]. Taken together,
these data indicate that IL-12 may play a key role in regulating
lung function during hMPV infection.
In conclusion, our studies demonstrate that IL-12p40 is
critically involved in the processes of lung inflammation, cytokine
release and airway hyperresponsiveness in mice experimentally
infected with hMPV. The results presented herein suggest that IL-
12p40 plays a central role in protection against hMPV infection
and support other indirect evidence of the involvement of lung
cytokines in the clinical manifestations of naturally acquired
hMPV disease. However, further studies analyzing the specific
production of IL-12p40 in the respiratory tract of hMPV-infected
individuals are needed. Determining the significance of the role of
IL-12p40 in immunity is important for our understanding of the
Figure 5. Cytokine and chemokine production in the lung of IL-12p40-KO mice infected with hMPV. WT and IL-12p40-KO mice were
infected i.n. with 5610
6 PFU of hMPV or mock-infected and sacrificed at day 7 after infection. BAL samples were collected from each group of mice
and assessed for cytokine/chemokine production by a multi-Plex Cytokine detection system. n=7–8 mice/group.*P,0.05.
doi:10.1371/journal.pone.0037173.g005
Figure 6. Lung function in IL-12p40-KO mice infected with hMPV. WT or IL-12p40-KO mice were infected with hMPV (5610
6 PFU/mice), and
airway resistance was measured at day 15 after hMPV infection. Change in airway resistance between baseline values after challenge with different
concentrations of aerosolized methacholine (0.1, 1, 10, 25, and 50 mg/ml) was measured by the Flexivent system (Resistance units=cmH2O.s/mL).
Values represent mean 6 SEM. n=4 mice/group. *P,0.05.
doi:10.1371/journal.pone.0037173.g006
IL-12p40 in Human Metapneumovirus Infection
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infection.
Methods
Virus stocks
hMPV (strain CAN97-83) initial stocks were provided by the
Respiratory Virus Section, Centers for Disease Control (CDC),
Atlanta, GA, with permission from Dr. Guy Boivin at the
Research Center in Infectious Diseases, Regional Virology
Laboratory, Laval University, Quebec City, Canada. Virus was
propagated and titrated in LLC-MK2 cells (ATCC, Manassas,
VA) in the presence of trypsin (Worthington, Lakewood NJ), as
described elsewhere [33], [57].
Ethic statement
Animal care and use were conducted in accordance with the
National Institutes of Health and Louisiana State University
institutional guidelines. The Louisiana State University Animal
Care and Use Committee specifically approved this study under
the protocol number: 09-050. Mice were housed in a temperature-
controlled room with proper darkness-light cycles, fed with
a regular diet, and maintained under the care of the Division of
Laboratory Animal Medicine facility, Louisiana State University,
Baton Rouge, Louisiana. The mice were sacrificed by an
intraperitoneal injection of ketamine and xylazine and exsangui-
nated via the femoral vessels.
Mice and infection protocol
Female and male B6.129S1-Il12b
tm1Jm/J (IL-12p40-KO) and
C57BL/6J WT were obtained from The Jackson Laboratory (Bar
Harbor, ME). All mice were bred in specific pathogen free
conditions and used when 7 to 10 weeks old. Under light
anesthesia, mice were infected i.n. with 50 ml of hMPV diluted in
PBS (final administered dose: 5610
6 PFU). In some experiments
mice were inoculated with inactivated virus. Virus stocks were
exposed for 10 minutes to UV irradiation using ultraviolet lamp
(254 nm wavelength). After this treatment, no infectious virus was
detected in the inoculum used when tested by plaque assay (not
shown). As mock treatment, mice were inoculated with an
equivalent volume of PBS (herein referred as mock).
Broncholaveolar lavage
To collect a bronchoalveolar lavage (BAL), the lungs were
flushed twice with ice-cold sterile PBS (1 ml). A total of 100 mlo f
this BAL fluid from each mouse was retained for cytospin analysis,
and the rest was immediately centrifuged and stored at 270uC
until analysis. BAL differential cell counts were determined using
morphogenic criteria under light microscopy of Wright-Giemsa-
stained cytospin with a total count of 200 cells per slide. Total
number of BAL cells was counted by trypan blue.
Detection of cytokines and chemokines
Levels of cytokines and chemokines in BAL fluid were
determined with the Milliplex MAP
TM 32-Mouse Plex Cytokine
detection system (Millipore, Billerica, MA) or Bio-Plex Pro
TM
assay (Bio-Rad, Hercules, CA), according to the manufacturer’s
instructions. The range of the sensitivity of the assays is 3.2 to
10000 pg/ml.
Pulmonary histopathology
For histological analysis, lungs were perfused and fixed in 10%
buffered formalin and embedded in paraffin. Multiple 4 mm-thick
sections were stained with haematoxylin & eosin (H&E) to assess
lung inflammation or periodic acid Schiff (PAS) to identify mucus-
secreting cells. A blind analysis and scoring for cellular infiltration
was performed by a board certified pathologist, as previously
described [58], [59]. Briefly, inflammatory infiltrates were scored
by enumerating the layers of inflammatory cells surrounding the
vessels and bronchioles. The number of abnormal perivascular
and peribronchial spaces divided by the total perivascular and
peribronchial spaces was the percentage reported as the pathology
score. Mucus index was quantified in additional lung sections
stained PAS to assess goblet cell hyperplasia. PAS stained slides
were digitally scanned using the high throughput slide scanner
NanoZoomer with a 206objective and areas of airway epithelium
were measured using the NanoZoomer Digital Pathology view
software (both from Hamamatsu Photonics, Hamamatsu City,
Japan). All airways present in the lung sections were analyzed. The
mucus index was calculated as follows: the area of airway
epithelium PAS positive/total area of the conducting airway
epithelium.
Lung viral replication
Lungs were removed from infected animals at days 1, 3, 5, and
7 after hMPV infection. Tissue samples were homogenized in 1 ml
of Dulbecco’s modified Eagle’s medium and centrifuged twice at
10,0006 g for 1 min at 4uC. Serial two-fold dilutions of the
supernatant were determined by plaque assay on LLC-MK2 cells
under methylcellulose overlay. Plaques were visualized 6 days later
by HRP staining, as previously described [33], [57].
Real time quantitative PCR
The first -strand cDNA was synthesized from RNA using the
Maxima First strand cDNA Synthesis kit (Fermentas, Maryland
MS) according to the manufacturer’s instructions. cDNA frag-
ments of interest were amplified using Maxima SYBR green/
ROX qPCR Master Mix (Fermentas) or Faststart Universal probe
master (Roche, Indianapolis, IN). For hMPV nucleoprotein (N)
gene, predesigned Taqman assay primers and probe were used
and MUC5b and MUC5ac, SYBR green assays primers were
designed as mentioned elsewhere [60]. All assays for MUC5ac,
MUC5b, hMPV, and GAPDH were run on the 7900HT Fast
Real-Time PCR System following suggested manufacturer’s
cycling parameters (Applied Biosystems, Foster City, CA). The
comparative CT (DDCT) method was used to quantitate the
expression of target genes which were normalized to endogenous
reference (GAPDH) expression in reference to transcripts from
uninfected and untreated control cells.
Pulmonary function testing
Lung function was measured invasively on anesthetized mice
using flexiVentH system (SCIREQ, Montreal, QC, Canada)
including the heart rate monitor to ensure that appropriate
anesthesia was maintained throughout the duration of ventilation.
Airways hyperresponsiveness (AHR) to methacholine was assessed
in mice infected for 15 d with hMPV as previously described [55].
AHR was measured after ultrasonic nebulization of 16 PBS
(baseline) and in response to increasing doses of methacholine (0.1,
1.0, 10, 25, and 50 mg/ml; acetyl-b-methylcholine chloride, MP
Biomedicals) delivered by ultrasonic nebulizer. Ventilation was
maintained at a rate of 150 breaths/minute, a tidal volume of
7.5 ml/kg, and a positive end expiratory pressure of 3 cm of
water. Mice were allowed to acclimate to the ventilator for 2–
3 minutes before initiation of readings, and three to four total lung
capacity functions were performed during this acclimation period
to prevent atelectasis and to ensure maximum airway and alveolar
IL-12p40 in Human Metapneumovirus Infection
PLoS ONE | www.plosone.org 8 May 2012 | Volume 7 | Issue 5 | e37173recruitment. Peak responses during each 5-min period were
determined for resistance. Respiratory mechanics were assessed
using the linear first-order single compartment model, which
provides resistance of the total respiratory system and the constant
phase model, which utilizes forced oscillation to differentiate
between airways resistance and peripheral tissue damping. Only
measurements with a coefficient of determination of 0.95 or
greater were used and measurements were repeated until a total of
3 pressure-volume curves and 3 single compartment perturbations,
each with acceptable coefficients of determination, were obtained.
The averages of these 3 measurements were determined for each
mouse and averaged for each experimental group.
Statistical analysis
Statistical significance was calculated by one-way ANOVA to
ascertain differences between groups, followed by a Tukey-
Kramer test to correct for multiple comparisons using Graph
Pad InStat 3 (GraphPad Software, La Jolla, CA). Each experiment
for the different parameters assessed was performed at least three
times. Unless otherwise indicated, results are expressed as mean 6
SEM.
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